Recursion Pharmaceuticals executives discussed the company’s artificial intelligence-driven drug discovery platform during a ...

Recursion Pharmaceuticals expanded its collaboration with Citeline to integrate real world data into its AI enabled ClinTech Platform. The partnership is aimed at refining clinical trial design and ...

Recursion Pharmaceuticals (RXRX) closed at $3.32 in the latest trading session, marking a -2.06% move from the prior day. This change lagged the S&P 500's daily gain of 0.62%. Meanwhile, the Dow ...

View Recursion Pharmaceuticals, Inc. Class A RXRX stock quote prices, financial information, real-time forecasts, and company news from CNN.

The technology sector is no longer asking what artificial intelligence can do for us. It is asking what AI can do for itself.

AI can’t be fully trusted, yet businesses depend on it. Explore the risks of bias, hallucinations, and adversarial ...

Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...

With the success of Apple TV+'s Dark Matter, this underrated sci-fi story needs a book-accurate remake as soon as possible.

Breakdown of the Silverquill Influence Commander precon from Secrets of Strixhaven, including commanders, new cards, reprints ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...